Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gritstone bio, Inc. - Common Stock (NQ: GRTS )

0.0322 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gritstone bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Gritstone bio Shares Jump After Updated Overall Survival Data From Colorectal Cancer Candidate
Via Benzinga
Block To 100? Plus This Analyst Slashes PT On Estée Lauder By 32%
  Barclays slashed the price target on Block, Inc. (NYSE: SQ) from $130 to $100. Block shares rose 1% to $60.70 in pre-market trading. 
Via Benzinga
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
From Gritstone bio
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Gritstone Oncology's Return On Capital Employed Overview
Benzinga Pro data, Gritstone Oncology (NASDAQ:GRTS) reported Q2 sales of $5.47 million. Earnings fell to a loss of $29.52 million, resulting in a 2.07% decrease from last quarter. 
Via Benzinga
Gritstone's Cancer Drug Shows Strong Tumor-Specific Responses In Various Settings
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
Via Benzinga
Goldman Sachs Is Bearish On Gritstone Bio: 'Avenues For Financing Are Likely Too Modest'
Gritstone bio Inc (NASDAQ: GRTS) has insufficient cash either to reach de-risking catalysts for its lead oncology program, GRANITE, or to support the clinical development of its second program, SLATE,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Earnings Outlook For Gritstone Oncology
Gritstone Oncology (NASDAQ:GRTS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Gritstone Bio's Earnings Outlook
Gritstone Bio (NASDAQ:GRTS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Gritstone Bio... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Wells Fargo raised the price target on Laredo Petroleum, Inc. (NYSE: LPI) from $72 to $113. Laredo Petroleum shares fell 2.8% to $71.00 in pre-market trading. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Quidel (NASDAQ:QDEL) shares incre... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Epizyme (NASDAQ:EPZM) shares incr... 
Via Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! It's time for another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge... 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.70% to 36,839.62 while the NASDAQ fell 1.57% to 15,583.77. The S&P also fell, dropping 0.03% to 4,794.93. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Hoth Therapeutics (NASDAQ: 
Via Benzinga
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.